ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer
Shaghayegh Nouruzi, Takeshi Namekawa, Nakisa Tabrizian, Maxim Kobelev, Olena Sivak, Joshua M Scurll, Cassandra Jingjing Cui, Dwaipayan Ganguli, Amina Zoubeidi
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFOXO transcription factor regulation · Pancreatic function and diabetes · Mechanisms of cancer metastasis
Original citation: JCI Insight. 2024;9(23):e185952. https://doi.org/10.1172/jci.insight.185952
Citation for this corrigendum: JCI Insight. 2025;10(15):e196861. https://doi.org/10.1172/jci.insight.196861
The Methods have been updated to indicate the source of the tissue microarray data. The added text is below.
Tissue microarray. The tissue microarray was generated in 2016 by the pathology core at the Vancouver Prostate Centre (VPC), using British Columbian Canadian prostate cancer specimens obtained from surgeries performed at Vancouver General Hospital and UBC Hospital.
The HTML and PDF versions have been updated online.